CymaBay Reports First Quarter 2023 Financial Results and Provides Corporate Update
Harish Shantharam, proven leader in building financial organizations to prepare for successful commercialization, appointed as…
Harish Shantharam, proven leader in building financial organizations to prepare for successful commercialization, appointed as…
Harish Shantharam, proven leader in building financial organizations to prepare for successful commercialization, appointed as…
Fortress is advancing several late-stage clinical assets with two NDA submissions anticipated in second half…
Fortress is advancing several late-stage clinical assets with two NDA submissions anticipated in second half…
MONT-SAINT-GUIBERT, Belgium, May 15, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the…
MONT-SAINT-GUIBERT, Belgium, May 15, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the…
Publication of promising Phase 1b data in Journal of Clinical Oncology supports plans for pivotal…
Publication of promising Phase 1b data in Journal of Clinical Oncology supports plans for pivotal…
Recently filed S-4 registration statement for proposed merger with Notable; expects to close the transaction…
Recently filed S-4 registration statement for proposed merger with Notable; expects to close the transaction…
– Commenced patient dosing in lorundrostat pivotal clinical program, for the treatment of patients with…
– Commenced patient dosing in lorundrostat pivotal clinical program, for the treatment of patients with…
– 1Q23 total revenue of $6.2M including collaborative revenue of $2.8M from the Company’s share…
– 1Q23 total revenue of $6.2M including collaborative revenue of $2.8M from the Company’s share…
Company has initiated pre-IND discussions with the FDA for its first AIM INJ indication NEXI-001…
Company has initiated pre-IND discussions with the FDA for its first AIM INJ indication NEXI-001…
PHOENIX, May 15, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the…
PHOENIX, May 15, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the…
REDWOOD CITY, Calif., May 15, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS),…
NEWS RELEASE – REGULATED INFORMATION15 MAY 2023, 4:00PM EDT / 22:00 CET MDxHealth…